Seaport Therapeutics, Inc. Insider Trading
SPTX
Insiders bought 335K on the open market and sold nothing.
Get an email when SPTX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3 | Denice Torres Director | Bought | 5,000 | $19.87 | 99K | 37% | Form 4 |
| Jun 22 | Robert J. Hombach Director | Bought | 13,000 | $18.14 | 236K | New | Form 4 |
| May 4 | Arch Venture Partners Xii, L.p. Large holder | Bought | 1,100,000 | $18.00 | $19.8M | 21% | Form 4 |
- Nov 3Denice TorresDirector · bought 5,000 at $19.8799K37% of stake
- Jun 22Robert J. HombachDirector · bought 13,000 at $18.14236KNew position
- May 4Arch Venture Partners Xii, L.p.Large holder · bought 1,100,000 at $18.00$19.8M21% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with SPTX
Held by ETFs
SPTX is in 3 US ETFs. The largest of them, with SPTX's weight in each:
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SPTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.